ProEthic Pharmaceuticals has launched Ibudone, a new prescription fixed combination of hydrocodone and ibuprofen for the short-term management of acute pain.
Subscribe to our email newsletter
Ibudone provides the highest hydrocodone or ibuprofen dosage available, 10mg of hydrocodone/200mg of ibuprofen in each tablet. Peak plasma levels are achieved in less than two hours. Ibudone is also available with 5mg hydrocodone/200mg of ibuprofen.
Carl Whatley, chairman and CEO of ProEthic, said: “By combining 10mg of hydrocodone with ibuprofen, Ibudone offers a powerful new option for relieving acute pain. It is important to note that Ibudone does not have the risk of acetaminophen liver toxicity, a leading cause of acute liver failure in the US. In addition, Ibudone also offers physicians schedule III prescribing convenience, a key issue with today’s busy practices.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.